The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Treatment Response of Keloidal and Hypertrophic Sternotomy Scars: Comparison Among Intralesional Corticosteroid, 5-Fluorouracil, and 585-nm Flashlamp-Pumped Pulsed-Dye Laser Treatments
Abstract
OBJECTIVE: To compare the clinical response of keloidal and hypertrophic scars after treatment with intralesional corticosteroid alone or combined with 5-fluorouracil (5-FU), 5-FU alone, and the 585-nm flashlamp-pumped pulsed-dye laser (PDL). DESIGN: Prospective, paired-comparison, randomized controlled trial. SETTING: A private ambulatory laser facility. PATIENTS: Ten patients with previously untreated keloidal or hypertrophic median sternotomy scars at least 6 months after surgery that were considered problematic by the patients. INTERVENTIONS: Five segments were randomly treated with 4 different regimens: (1) laser radiation with a 585-nm PDL (5 J/cm(2)); (2) intralesional triamcinolone acetonide (TAC) (20 mg/mL); (3) intralesional 5-FU (50 mg/mL); and (4) intralesional TAC (1 mg/mL) mixed with 5-FU (45 mg/mL). One segment of each scar received no treatment and served as a control. MAIN OUTCOME MEASURES: Scar height, erythema, and pliability were evaluated before and every 8 weeks after treatment. Patients' subjective evaluations were tabulated. Histologic sections of segments were examined in 1 biopsy sample per segment at week 32. RESULTS: There was a statistically significant clinical improvement in all treated segments. No significant difference in treatment outcome vs method of treatment was noted. However, intralesional formulas resulted in faster resolution than the PDL: scar induration responded better to intralesional formulas, scar texture responded better to the PDL, and scar erythema responded the same as the control with all treatments. Adverse sequelae, including hypopigmentation, telangiectasia, and skin atrophy, were observed in 50% (5/10) of the segments that received corticosteroid intralesionally alone. No long-term adverse sequelae were demonstrated in the segments treated with other modalities. CONCLUSIONS: Clinical improvement of keloidal and hypertrophic scars after treatment with intralesional corticosteroid alone or combined with 5-FU, 5-FU alone, and PDL seemed comparable, with the exceptions of the incidence of adverse reactions, which were most common with intralesional corticosteroid. Intralesional 5-FU is comparable to the other therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Singer, A. J., & Clark, R. A. F. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909023411006 · Cited by 6,106
Sullivan, T., Smith, J., Kermode, J., Mclver, E., & Courtemanche, D. J. (1990) · Journal of Burn Care & Rehabilitation · doi:10.1097/00004630-199005000-00014 · Cited by 844
Wound healing in glaucoma filtering surgery
Skuta, G. L., & Parrish, R. K. (1987) · Survey of Ophthalmology · doi:10.1016/0039-6257(87)90091-9 · Cited by 630
Five-year Follow-up of the Fluorouracil Filtering Surgery Study
THE FLUOROURACIL FILTERING SURGERY STUDY GROUP (1996) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(14)70431-3 · Cited by 526
The molecular basis of keloid and hypertrophic scar formation
Tuan, T.-L., & Nichter, L. S. (1998) · Molecular Medicine Today · doi:10.1016/s1357-4310(97)80541-2 · Cited by 431
Treatment of keloid sternotomy scars with 585 nm flashlamp-pumped pulsed-dye laser
Alster, T. S., & Williams, C. M. (1995) · The Lancet · doi:10.1016/s0140-6736(95)91989-9 · Cited by 415
Treatment of Inflamed Hypertrophic Scars Using Intralesional 5-FU
Fitzpatrick, R. E. (1999) · Dermatologic Surgery · doi:10.1046/j.1524-4725.1999.08165.x · Cited by 368
HYPERTROPHIC SCARS AND KELOIDS A Collective Review
KETCHUM, L. D., COHEN, L. K., & MASIFRS, F. W. (1974) · Plastic and Reconstructive Surgery · doi:10.1097/00006534-197402000-00004 · Cited by 254
Pulsed dye laser therapy for sun damaged skin
Zelickson, B. D., Kilmer, S. L., Bernstein, E., Chotzen, V. A., Dock, J., Mehregan, D., & Coles, C. (1999) · Lasers in Surgery and Medicine · doi:10.1002/(sici)1096-9101(1999)25:3<229::aid-lsm7>3.0.co;2-d · Cited by 243
Fluorouracil for the Treatment of Massive Periretinal Proliferation
Blumenkranz, M. S., Ophir, A., Claflin, A. J., & Hajek, A. (1982) · American Journal of Ophthalmology · doi:10.1016/0002-9394(82)90239-2 · Cited by 220
Selective non-ablative wrinkle reduction by laser
Bjerring, P., Egevist, H., Clement, M., Heickendorff, L., & Kiernan, M. (2000) · Journal of Cutaneous Laser Therapy · doi:10.1080/14628830050516542 · Cited by 205
Keloids and hypertrophic scars: Review and treatment strategies
Urioste, S. S., Arndt, K. A., & Dover, J. S. (1999) · Seminars in Cutaneous Medicine and Surgery · doi:10.1016/s1085-5629(99)80040-6 · Cited by 181
Laser Treatment of Erythematous/Hypertrophic and Pigmented Scars in 26 Patients
Dierickx, C., Goldman, M. P., & Fitzpatrick, R. E. (1995) · Plastic and Reconstructive Surgery · doi:10.1097/00006534-199501000-00012 · Cited by 180
SERUP, J., & AGNER, T. (1990) · Clinical and Experimental Dermatology · doi:10.1111/j.1365-2230.1990.tb02087.x · Cited by 173
Non-ablative subsurface remodeling: Clinical and histologic evaluation of a 1320-nm Nd:YAG laser
Goldberg, D. J. (1999) · Journal of Cutaneous Laser Therapy · doi:10.1080/14628839950516805 · Cited by 171
Cutaneous tissue repair: Practical implications of current knowledge. II
Reed, B. R., & Clark, R. A. F. (1985) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(85)70242-3 · Cited by 159
Perilesional linear atrophy and hypopigmentation after intralesional corticosteroid therapy
Friedman, S. J., Butler, D., & Pittelkow, M. R. (1988) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(88)70209-1 · Cited by 123
Manuskiatti, W., FITZPATRICK, R. E., & Goldman, M. P. (2001) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2001.116580 · Cited by 108
Self-citationUse of Er:YAG laser for benign skin disorders
ŝek-Olup, B. D., & Vedlin, B. (1997) · Lasers in Surgery and Medicine · doi:10.1002/(sici)1096-9101(1997)21:1<7::aid-lsm2>3.0.co;2-u · Cited by 105
Mallick, K. S., Hajek, A. S., & Parrish, R. K., II (1985) · Archives of Ophthalmology · doi:10.1001/archopht.1985.01050090150052 · Cited by 59
Treatment of Keloid Sternotomy Scars with 585-nm Flashlamp-Pumped Pulsed-Dye Laser
Brod, B. A. (1996) · Dermatitis · doi:10.1097/01206501-199609000-00018 · Cited by 10
Cited by
Broughton, G., Janis, J. E., & Attinger, C. E. (2006) · Plastic and Reconstructive Surgery · doi:10.1097/01.prs.0000222562.60260.f9 · Cited by 917
Burn injury: Challenges and advances in burn wound healing, infection, pain and scarring
Wang, Y., Beekman, J., Hew, J., Jackson, S., Issler-Fisher, A. C., Parungao, R., Lajevardi, S. S., Li, Z., & Maitz, P. K. M. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.09.018 · Cited by 696
Keloid Pathogenesis and Treatment
Al-Attar, A., Mess, S., Thomassen, J. M., Kauffman, C. L., & Davison, S. P. (2006) · Plastic and Reconstructive Surgery · doi:10.1097/01.prs.0000195073.73580.46 · Cited by 553
Acne Scars: Pathogenesis, Classification and Treatment
Fabbrocini, G., Annunziata, M. C., D′Arco, V., De Vita, V., Lodi, G., Mauriello, M. C., Pastore, F., & Monfrecola, G. (2010) · Dermatology Research and Practice · doi:10.1155/2010/893080 · Cited by 440
Hypertrophic Scars and Keloids: Etiology and Management
Alster, T. S., & Tanzi, E. L. (2003) · American Journal of Clinical Dermatology · doi:10.2165/00128071-200304040-00003 · Cited by 379
Metadata
- Authors
- Manuskiatti, W.
- Venue
- Archives of Dermatology
- Publisher
- American Medical Association (AMA)
- Published
- 2002-09-01
- Volume
- 138
- Issue
- 9
- Pages
- 1149
- ISSN
- 0003-987X (ISSN-L)
- OpenAlex
- W2043778734
- Cited by
- 352
- References
- 21
- FWCI
- 10.25
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.